This scholarship page was last updated on 02 October 2024. Some details may have changed since then. Please check the National Institutes of Health website or the National Institutes of Health page for current opportunities.

Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)

National Institutes of Health
Tipo

Research/project funding

Posted on:

Funding Opportunity RFA-CA-25-013 from the NIH Guide for Grants and Contracts. The overall goal of this UG3/UH3 Exploratory/Developmental phased initiative is to support the discovery and development of novel natural products that are safe, nontoxic, and efficacious for cancer interception and prevention. 1. Purpose of UG3: Select clinically relevant targets and develop and validate assays for bioactivity as well as toxicity screening 2. Purpose of UH3 phase: Screening libraries, structure elucidation, full-scale characterization, efficacy testing, and development of the screened agents.

More Information

Tipo

Research/Project Funding

Posted on:

Stati Uniti